SCHEMBL27286459

SCHEMBL27286459

Cc1ccc2c(Cl)c(F)ccc2c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.46
CYP2A6 P11509 4/20 0.46
LMNA P02545 3/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ESR1 P03372 5/20 0.42
ESR2 Q92731 5/20 0.42
TDP1 Q9NUW8 1/20 0.40
TNF P01375 1/20 0.37
RIPK1 Q13546 1/20 0.37
PTGES O14684 1/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
DAO P14920 1/20 0.34
BCL2L1 Q07817 1/20 0.34
MCL1 Q07820 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14525486 0.79 CYP1A2 (0.50) CYP1A2CYP2A6LMNAKDM4EALDH1A1
SCHEMBL14444114 0.79 CYP1A2 (0.50) CYP1A2CYP2A6LMNAKDM4EALDH1A1
SCHEMBL765694 0.79 LMNA (0.59) CYP1A2CYP2A6LMNAKDM4EALDH1A1
SCHEMBL20802476 0.78 CYP1A2 (0.39) CYP1A2CYP2A6LMNAKDM4EALDH1A1
SCHEMBL2723074 0.77 CYP2A6 (0.52) CYP1A2CYP2A6LMNAKDM4EALDH1A1
SCHEMBL14525492 0.76 CYP1A2 (0.46) CYP1A2CYP2A6LMNAKDM4EALDH1A1
SCHEMBL3828940 0.76 NCEH1 (0.45) CYP2A6LMNAKDM4EALDH1A1GAA
SCHEMBL15976515 0.76 ESR1 (0.58) CYP1A2CYP2A6LMNAKDM4EALDH1A1
SCHEMBL14606248 0.76 CYP1A2 (0.46) CYP1A2CYP2A6LMNAKDM4EALDH1A1
SCHEMBL30887721 0.76 ESR1 (0.55) CYP1A2ESR1ESR2DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024107686-A1 MACROCYCLIC KRAS INHIBITORS AND METHODS OF USE AMGEN INC. (US) 2024-05-23 WO disclosed